Truesdell Alexander G, Davies Rhian, Eltelbany Moemen, Megaly Michael, Rosner Carolyn, Cilia Lindsey A
Virginia Heart Falls Church, VA.
Inova Heart and Vascular Institute Falls Church, VA.
US Cardiol. 2023 Apr 4;17:e03. doi: 10.15420/usc.2022.26. eCollection 2023.
Technological and procedural innovations presently permit the safe and effective performance of increasingly complex percutaneous coronary interventions, while new mechanical circulatory support devices offer circulatory and ventricular support to patients with severely reduced left ventricular systolic function and deranged cardiovascular hemodynamics. Together, these advances now permit the application of complex percutaneous coronary interventions to higher-risk patients who might otherwise be left untreated. Increasing observational data support the use of mechanical circulatory support in appropriate complex and high-risk patients as part of a larger multidisciplinary heart team treatment plan. In-progress and upcoming randomized clinical trials may provide higher-quality evidence to better guide management decisions in the near future.
目前,技术和操作上的创新使得越来越复杂的经皮冠状动脉介入治疗能够安全有效地进行,同时新型机械循环支持设备为左心室收缩功能严重降低且心血管血流动力学紊乱的患者提供循环和心室支持。这些进展共同使得复杂的经皮冠状动脉介入治疗能够应用于那些否则可能得不到治疗的高危患者。越来越多的观察性数据支持在合适的复杂高危患者中使用机械循环支持,作为更大的多学科心脏团队治疗计划的一部分。正在进行和即将开展的随机临床试验可能会提供更高质量的证据,以便在不久的将来更好地指导管理决策。